The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining different types of biological data, like genomics and other ‘omics’, will become ...

Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC characterization.

Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.